Status:
UNKNOWN
Meridian Energy Changes of Head and Neck Cancer Patients After Chemotherapy or Radiotherapy
Lead Sponsor:
Liao Jian An
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
This trial is conducted by using MEAD to detect the meridian changes in patients with head and neck cancer after conventional treatment of chemotherapy or radiotherapy.
Detailed Description
The purpose of this research is observe the change of meridian energy in patients have be diagnosed with head and neck cancer. The instrument we use is a non-invasive device called meridian energy ana...
Eligibility Criteria
Inclusion
- patients with head and neck cancer, included nasopharyngeal carcinoma, laryngeal cancer, oropharyngeal cancer, ear and oral cancer, hypopharyngeal cancer, salivary-gland carcinoma. Aged between 20 years old to 75years old, no gender difference.
- patients with head and neck cancer has not received surgery yet, and will plan to accept chemotherapy and/or radiotherapy.
- recurrent head and neck cancer, and expect to received chemotherapy and/or radiotherapy.
- patient with vital sings stableness, conscious clear, and have ability to recognize the contain of trail and sign consent.
- not accept other adjuvant therapy.
- no brain metastasis or psychosis, and will to join whole course as well as accept assessments.
Exclusion
- Aged less than 20 years old and over 75 years old。
- Patients be diagnosed with head and neck cancer, and accepted surgery, or already finished chemotherapy and/or radiotherapy.
- patient with brain metastasis, conscious unclear, and have not able to recognize the contain of trail and sign consent.
- Accept other adjuvant therapy and chemotherapy and/or radiotherapy simultaneously.
- Combined with serious organs failure。
- Have contraindication in chemotherapy or radiotherapy.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2024
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04872517
Start Date
April 1 2021
End Date
March 31 2024
Last Update
September 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Cung Memorial Hospital
Keelung, Taiwan, 20401